Differentiating between natural progesterone and synthetic progestins: clinical implications for premenstrual syndrome and perimenopause management
Martorano, J.T.; Ahlgrimm, M.; Colbert, T.
Comprehensive Therapy 24(6-7): 336-339
1998
ISSN/ISBN: 0098-8243 PMID: 9669099 Document Number: 494619
Critical differences between natural progesterone and synthetic progestins are often misunderstood. Synthetic progestins should not be used interchangeably with natural progesterone. This article describes their differences and the clinical implications for their use in managing premenstrual syndrome and perimenopause.
Document emailed within 1 workday
Related Documents
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850West, C.P. 1990: Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome European Journal of Obstetrics Gynecology and Reproductive Biology 34(1-2): 119-128
Osofsky, H.J.; Keppel, W.; Kuczmierczyk, A.R. 1988: Evaluation and management of premenstrual syndrome in clinical psychiatric practice Journal of Clinical Psychiatry 49(12): 494-498
Guzeloglu Kayisli, O.; Kayisli, U.A.; Basar, M.; Semerci, N.; Schatz, F.; Lockwood, C.J. 2015: Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding Plos one 10(10): E0137855
Watanabe, H.; Lau, D.C.; Guyn, H.L.; Wong, N.L. 1997: Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome Clinical and Investigative Medicine 20(4): 211-223
Botella, J.; Duranti, E.; Viader, V.; Duc, I.; Delansorne, R.; Paris, J. 1995: Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells Journal of Steroid Biochemistry and Molecular Biology 55(1): 77-84
Harrison, W.M.; Endicott, J.; Rabkin, J.G.; Nee, J. 1984: Treatment of premenstrual dysphoric changes: clinical outcome and methodological implications Psychopharmacology Bulletin 20(1): 118-122
Elkik, F.; Mauvais-Jarvis, P. 1980: The role of progesterone and progestins in hydroelectrolytic metabolism La Nouvelle Presse Medicale 9(1): 35-38
Schiola, A.; Lowin, J.; Lindemann, M.; Patel, R.; Endicott, J. 2011: The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 14(5 Suppl. 1): S93-S95
Carstairs, M.W.; Talbot, D.J. 1981: A placebo controlled trial of Tenavoid in the management of the premenstrual syndrome British Journal of Clinical Practice 35(11-12): 403-409
Freeman, E.W.; Halbreich, U.; Grubb, G.S.; Rapkin, A.J.; Skouby, S.O.; Smith, L.; Mirkin, S.; Constantine, G.D. 2012: An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome Contraception 85(5): 437-445
Manuilova, I.A.; Melkumova, I.S.; Evdokimova, V.I.; Saluén'ia, A.I. 1974: Changes in the function of the liver after use of synthetic progestins Terapevticheskii Arkhiv 46(4): 14-20
Fehring, R.J.; Mu, Q. 2014: Cohort efficacy study of natural family planning among perimenopause age women Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 43(3): 351-358
Demidova, T.V. 1975: Treatment of endocrine forms of sterility with synthetic progestins Sovetskaia Meditsina 6: 35-40
Chuong, C.J.; Coulam, C.B.; Bergstralh, E.J.; O'Fallon, W.M.; Steinmetz, G.I. 1988: Clinical trial of naltrexone in premenstrual syndrome Obstetrics and Gynecology 72(3 Pt 1): 332-336
Moser, C.; Zoderer, D.; Luef, G.; Rauchenzauner, M.; Wildt, L.; Griesmacher, A.; Seger, C. 2012: Simultaneous online SPE-LC-MS/MS quantification of six widely used synthetic progestins in human plasma Analytical and Bioanalytical Chemistry 403(4): 961-972
Manuilova, I.A.; Sotnikova, E.I. 1978: Treatment of hyperplastic processes in the endometrium of women of child-bearing age using different types of synthetic progestins Akusherstvo i Ginekologiia 3: 39-42
Ahmad, M.E.; Shadab, G.G.; Azfer, M.A.; Afzal, M. 2001: Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro Mutation Research 494(1-2): 13-20
Brotherston, J. 2015: Contraception meets HRT: seeking optimal management of the perimenopause British Journal of General Practice: the Journal of the Royal College of General Practitioners 65(638): E630-E632
Africander, D.J.; Storbeck, K.-H.; Hapgood, J.P. 2014: A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A) Journal of Steroid Biochemistry and Molecular Biology 143: 404-415